Education
About Us
Working with TipRanks
Follow Us
Pascal Biosciences Inc (TSE:NEVI)
:NEVI
Total Valuation
Pascal Biosciences Inc has a market cap or net worth of C$1.59M. The enterprise value is C$1.73M.
Market CapC$1.59M
Enterprise ValueC$1.73M
Share Statistics
Pascal Biosciences Inc has 39,662,727 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding39,662,727
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Pascal Biosciences Inc’s return on equity (ROE) is -0.28 and return on invested capital (ROIC) is -23.94%.
Return on Equity (ROE)-0.28
Return on Assets (ROA)-0.16
Return on Invested Capital (ROIC)-23.94%
Return on Capital Employed (ROCE)-0.30
Revenue Per Employee847.83K
Profits Per Employee-137.54K
Employee Count2
Asset Turnover0.99
Inventory Turnover5.81
Valuation Ratios
The current PE Ratio of Pascal Biosciences Inc is ―. Pascal Biosciences Inc’s PEG ratio is 0.26.
PE Ratio―
PS Ratio1.17
PB Ratio2.05
Price to Fair Value2.05
Price to FCF31.93
Price to Operating Cash Flow25.55
PEG Ratio0.26
Income Statement
In the last 12 months, Pascal Biosciences Inc had revenue of 1.70M and earned -275.07K in profits. Earnings per share was >-0.01.
Revenue1.70M
Gross Profit396.31K
Operating Income-290.45K
Pretax Income-275.07K
Net Income-275.07K
EBITDA-32.66K
Earnings Per Share (EPS)>-0.01
Cash Flow
In the last 12 months, operating cash flow was 62.10K and capital expenditures 3.00, giving a free cash flow of 62.10K billion.
Operating Cash Flow62.10K
Free Cash Flow62.10K
Free Cash Flow per Share<0.01
Dividends & Yields
Pascal Biosciences Inc pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.42
52-Week Price Change-33.33%
50-Day Moving Average0.04
200-Day Moving Average0.05
Relative Strength Index (RSI)46.68
Average Volume (3m)55.49K
Important Dates
Pascal Biosciences Inc upcoming earnings date is Apr 24, 2026, TBA (Confirmed).
Last Earnings DateMar 20, 2026
Next Earnings DateApr 24, 2026
Ex-Dividend Date―
Financial Position
Pascal Biosciences Inc as a current ratio of 0.75, with Debt / Equity ratio of 25.20%
Current Ratio0.75
Quick Ratio0.45
Debt to Market Cap0.12
Net Debt to EBITDA-4.35
Interest Coverage Ratio-5.38
Taxes
In the past 12 months, Pascal Biosciences Inc has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Pascal Biosciences Inc EV to EBITDA ratio is -65.06, with an EV/FCF ratio of 34.22.
EV to Sales1.25
EV to EBITDA-65.06
EV to Free Cash Flow34.22
EV to Operating Cash Flow34.22
Balance Sheet
Pascal Biosciences Inc has C$102.17K in cash and marketable securities with C$244.21K in debt, giving a net cash position of -C$142.04K billion.
Cash & Marketable SecuritiesC$102.17K
Total DebtC$244.21K
Net Cash-C$142.04K
Net Cash Per Share>-C$0.01
Tangible Book Value Per Share>-C$0.01
Margins
Gross margin is 41.26%, with operating margin of -17.13%, and net profit margin of -16.22%.
Gross Margin41.26%
Operating Margin-17.13%
Pretax Margin-16.22%
Net Profit Margin-16.22%
EBITDA Margin-1.93%
EBIT Margin-17.13%
Analyst Forecast
The average price target for Pascal Biosciences Inc is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-6.85%
EPS Growth Forecast22.09%